Soma Takehisa, Ohta Kaisaku, Yamashita Runa, Sasai Kazumi
Veterinary Diagnostic Laboratory, Marupi Lifetech Co., Ltd., 103 Fushiocho, Ikeda, Osaka 563-0011, Japan.
Laboratory of Veterinary Internal Medicine, Department of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-Orai-Kita, Izumisano, Osaka 598-8531, Japan.
J Vet Med Sci. 2019 Feb 19;81(2):252-255. doi: 10.1292/jvms.18-0472. Epub 2018 Dec 12.
To evaluate the accuracy of hemagglutination inhibition (HI) test as the index of feline panleukopenia virus (FPV)-protective ability, sera from 153 FPV-vaccinated cats aged ≥7 months with HI titer of <1:10-1:40, were examined for serum neutralizing (SN) antibody. SN antibody was detected (≥1:10) in 33 (62.3%) of 53 HI antibody-negative cats, and ranged <1:10-1:160. This suggests that FPV-antibody detection sensitivity of HI test is lower than SN test, and SN test is more suitable for the assessment of FPV-vaccine effect than HI test especially in cats with negative or low HI titer. SN titer was 1:32, FPV-protective threshold, or higher in all cats with HI titers of ≥1:20, suggesting it may be appropriate to set protective HI threshold at 1:20.
为评估血凝抑制(HI)试验作为猫泛白细胞减少症病毒(FPV)保护能力指标的准确性,对153只年龄≥7个月、HI效价<1:10 - 1:40的接种FPV疫苗的猫的血清进行了血清中和(SN)抗体检测。在53只HI抗体阴性的猫中,有33只(62.3%)检测到SN抗体(≥1:10),效价范围为<1:10 - 1:160。这表明HI试验检测FPV抗体的敏感性低于SN试验,并且SN试验比HI试验更适合评估FPV疫苗效果,尤其是对于HI效价为阴性或低的猫。所有HI效价≥1:20的猫的SN效价均为1:32(FPV保护阈值)或更高,这表明将保护性HI阈值设定为1:20可能是合适的。